G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $634,678 | -40.9% | 440,633 | +2.1% | 0.00% | – |
| Q2 2023 | $1,074,813 | -8.5% | 431,652 | -1.5% | 0.00% | – |
| Q1 2023 | $1,174,895 | +60933.5% | 438,394 | +23.7% | 0.00% | – |
| Q4 2022 | $1,925 | -100.0% | 354,539 | +2.1% | 0.00% | -100.0% |
| Q3 2022 | $4,337,000 | +156.9% | 347,255 | +1.6% | 0.00% | – |
| Q2 2022 | $1,688,000 | -66.8% | 341,895 | -48.8% | 0.00% | -100.0% |
| Q1 2022 | $5,077,000 | -30.5% | 668,140 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $7,303,000 | -15.4% | 715,373 | +11.2% | 0.00% | 0.0% |
| Q3 2021 | $8,630,000 | -35.5% | 643,103 | +5.4% | 0.00% | -50.0% |
| Q2 2021 | $13,390,000 | +1.0% | 610,324 | +10.7% | 0.00% | 0.0% |
| Q1 2021 | $13,261,000 | +52.4% | 551,183 | +13.9% | 0.00% | +100.0% |
| Q4 2020 | $8,704,000 | +61.7% | 483,840 | +3.8% | 0.00% | 0.0% |
| Q3 2020 | $5,383,000 | -52.6% | 466,128 | -0.4% | 0.00% | -50.0% |
| Q2 2020 | $11,351,000 | +125.0% | 467,921 | +2.2% | 0.00% | +100.0% |
| Q1 2020 | $5,045,000 | -77.0% | 457,835 | -44.9% | 0.00% | -50.0% |
| Q4 2019 | $21,974,000 | +140.7% | 831,410 | +107.5% | 0.00% | 0.0% |
| Q3 2019 | $9,128,000 | -21.8% | 400,716 | +5.3% | 0.00% | -33.3% |
| Q2 2019 | $11,669,000 | +125.1% | 380,600 | +21.9% | 0.00% | +200.0% |
| Q1 2019 | $5,183,000 | -51.5% | 312,230 | -44.1% | 0.00% | -50.0% |
| Q4 2018 | $10,688,000 | -19.2% | 558,126 | +120.6% | 0.00% | -50.0% |
| Q3 2018 | $13,227,000 | +38.7% | 252,965 | +15.3% | 0.00% | +33.3% |
| Q2 2018 | $9,535,000 | +38.4% | 219,411 | +18.0% | 0.00% | +50.0% |
| Q1 2018 | $6,890,000 | +268.1% | 185,977 | +97.1% | 0.00% | +100.0% |
| Q4 2017 | $1,872,000 | -12.8% | 94,366 | +9.3% | 0.00% | 0.0% |
| Q3 2017 | $2,148,000 | +1106.7% | 86,305 | +744.5% | 0.00% | – |
| Q2 2017 | $178,000 | – | 10,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |